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Abstract
The prevalence, effect on health outcomes, and economic impact of chronic kidney disease (CKD) 
have created interest in self-management interventions to help slow disease progression to kidney 
failure. Seven studies were reviewed to identify knowledge gaps and future directions for research. 
All studies were published between 2010 and 2013; no investigations were conducted in the 
United States. Knowledge gaps included the focus on medical self-management tasks with no 
attention to role or emotional tasks, lack of family involvement during intervention delivery, and 
an inability to form conclusions about the efficacy of interventions because methodological rigor 
was insufficient. Educational content varied across studies. Strategies to improve self-management 
skills and enhance self-efficacy varied and were limited in scope. Further development and testing 
of theory-based interventions are warranted. There is a critical need for future research using well-
designed trials with appropriately powered sample sizes, well-tested instruments, and clear and 
consistent reporting of results.
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Chronic kidney disease (CKD) is a national public health problem affecting 26 million 
Americans (Coresh et al., 2007) and 6 in 10 Americans are at risk for developing the disease 
in their lifetime (Grams, Chow, Segev, & Coresh, 2013). The prevalence, effect on health 
outcomes (CKD Prognosis Consortium, 2010; Plantinga et al., 2011), and economic impact 
(Honeycutt et al., 2013; United States [U.S.] Renal Data System, 2013) have created a 
national focus to slow progression of CKD, including recognition as a priority objective 
within Healthy People 2020 (Healthy People 2020, 2013). The need for patients to self-
manage their care is important for optimal patient outcomes in chronic disease (Lorig, Ritter, 
Villa, & Armas, 2009; Lorig et al., 2008) and is vital for people with CKD who need 
effective self-management to slow disease progression to end stage renal disease (ESRD).
Self-management is conceptually defined as a process in which people perform day-to-day 
activities in the management of chronic disease (Lorig & Holman, 2003). This definition 
includes the three attributes of self-management described by Schilling, Knafl, and Grey 
(2002) - process, activities, and goals – and is consistent with the assertion that chronic 
disease management occurs in the context of daily living (Grey, Knafl, & McCorkle, 2006; 
Schilling et al., 2002). Slowing disease progression in CKD requires daily performance of 
key self-management behaviors that include adherence to angiotensin-converting enzyme 
inhibitor (ACE-I) or angiotensin receptor blocker (ARB) medications, avoidance of 
nonsteroidal anti-inflammatory drugs (NSAIDS), diet modifications, glycemic control, 
regular exercise, systolic blood pressure control, and tobacco avoidance (Tuot et al., 2013).
Supporting self-management enables patients to self-identify problems and provides 
techniques to help them make decisions, take action, and alter behaviors (U.S. Department 
of Defense, 2012). Lorig and Holman (2003) recommend the inclusion of six core self-
management skills in self-management support programs: action planning, decision-making, 
patient-provider partnerships, problem solving, resource utilization, and self-tailoring. 
Development of these skills will enable people to accomplish key self-management tasks 
associated with medical, role, and emotional management (Battersby et al., 2010; Lorig & 
Holman, 2003),
Self-management of Stages 1-4 CKD is an emerging area in nephrology. Initial studies 
examining the efficacy of self-management interventions have only been reported in the last 
few years. The purpose of this integrative review of CKD self-management interventions is 
to identify knowledge gaps and future directions for research. Three questions guided this 
review: (1) What components of self-management were included? (2) What methods were 
used when testing the interventions? (3) Were the interventions efficacious in improving 
CKD patient outcomes?
Methods
This integrative review followed the processes identified by Cooper (1989). A 
comprehensive computerized search of EBSCOhost Cumulative Index to Nursing and Allied 
Health (CINAHL), OVID MEDLINE, Web of Science, and EMBASE was conducted at the 
university library by an experienced nursing librarian using four exploded search terms. 
“Kidney diseases” was combined using “AND” with “self-care,” “OR” “medication 
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adherence,” “OR” “patient education as topic” to find 494 citations. Reference lists were 
hand searched to locate additional literature. Studies were retained for review if they were 
written in English, included adults 18 years of age or older who had Stage 1-4 CKD, 
included an experimental or quasi-experimental design, and tested a self-management 
intervention. Studies were excluded if any of the participants had Stage 5 CKD or ESRD; 
were at risk for, but did not have, CKD; or if the intervention was solely educational in 
nature. Seven studies met the inclusion criteria. All were published between 2010 and 2013. 
Each study was read in detail by two authors, with data extracted into tables by one author 
and independently verified by a second author. Discrepancies were discussed until 
differences were resolved and consensus was reached.
Results
Components of the Interventions
Systematic efforts to improve knowledge, self-management, or self-efficacy were included 
in all studies. Table 1 summarizes these findings.
Knowledge—Knowledge development was the most frequent component of the tested 
interventions. Each study included some education; however, no investigation included all 
content associated with key CKD self-management behaviors. As shown in Table 1, the 
most frequently delivered educational content focused on nutrition, diet modifications, 
eating out, or reading food labels (Choi & Lee, 2012; Flesher et al., 2011; Kazawa & 
Monyama, 2013; Walker, Marshall, & Polaschek, 2013). Educational content associated 
with the other key components of CKD self-management in decreasing order of frequency 
included exercise (Flesher et al., 2011; Kazawa & Monyama, 2013; Walker et al., 2013), 
systolic blood pressure control (Byrne, Khunti, Stone, Farooqu, & Carr, 2011; Williams, 
Manias, Walker, & Gorelik, 2012), adherence to ACE-I or ARB therapy (Kazawa & 
Monyama, 2013; Williams et al. , 2012), and glycemic control (Kazawa & Monyama, 2013). 
None of the studies included content on avoidance of NSAIDS or smoking cessation/
tobacco avoidance.
Additional educational content was diverse. The most frequently delivered content was 
associated with hypertension (Byrne et al., 2011; Walker et al., 2013; Williams et al., 2012) 
or self-management (Choi & Lee, 2012; Flesher et al., 2011; Lin, Tsai, Lin, Hwang, & 
Chen, 2013). Other educational content in decreasing order of frequency included CKD and 
kidney health (Choi & Lee, 2012; Walker et al., 2013), diabetes and nephropathy (Kazawa 
& Monyama, 2013; Walker et al., 2013), a review of medications (Walker et al., 2013; 
Williams et al., 2012), kidney replacement therapies (Choi & Lee, 2012), foot care (Kazawa 
& Monyama, 2013), and stress or emotional management (Kazawa & Monyama, 2013).
Self-management skills—Three self-management skills, action planning, problem-
solving, and enhancing patient-provider partnerships, were evident in the tested 
interventions. There was no evidence of decision making, resource utilization, or self-
tailoring.
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Action planning was used most frequently and included in five studies. Goal settings, 
strategies to achieve goals, and self-evaluation of strategies to achieve goals were used in 
one study (Lin et al., 2013). In another (Byrne et al., 2011), participants developed an action 
plan to set, achieve, and maintain goals for blood pressure control, but no additional follow-
up was conducted. Goal setting was included in four other studies (Flesher et al., 2011; 
Kazawa & Monyama, 2013; Lin et al., 2013; Walker et al., 2013); it was not clear if an 
action plan was established or whether there was any follow-up on these goals.
Problem-solving was included in two studies. Participants in one were instructed to identify 
target problems and self-monitor activities to determine causes of problems (Lin et al., 
2013). In a second study, concerns and barriers to taking medications were identified 
(Williams et al., 2012). Neither study described if nor how they taught problem-solving 
skills.
Enhancing patient-provider partnerships was included in three studies. Self-monitoring of 
blood pressure (Kazawa & Monyama, 2013; Walker et al., 2013; Williams et al., 2012), 
blood glucose (Kazawa & Monyama, 2013; Walker et al., 2013), or exercise (Walker et al., 
2013) was used in all three studies, presumably to enhance patient-provider partnerships by 
communicating accurate information to the provider. In one, the interventionists acted as 
advisors to patients and primary physicians to foster good communication between the two 
(Kazawa & Monyama, 2013).
Self-efficacy—Efforts to enhance self-efficacy were included in five studies (see Table 1). 
In one (Lin et al., 2013), modeling of self-management behaviors, vicarious experience by 
observing others, and recognition of outcome performance were used to improve self-
efficacy. In another (Williams et al., 2012), self-efficacy was enhanced vicariously when 
people described daily medication management on video clips. A final study (Kazawa & 
Monyama, 2013) used positive feedback when changes in target behaviors were achieved. 
Strategies to improve self-efficacy were not described in two other studies (Byrne et al., 
2011; Flesher et al., 2011).
Methods Used When Testing Interventions
Design—As shown in Table 2, the studies included three randomized controlled trials 
(RCTs; Byrne et al., 2011; Flesher et al., 2011; Williams et al., 2012) and four quasi-
experimental designs (Choi & Lee, 2012; Kazawa & Monyama, 2013; Lin et al., 2013; 
Walker et al., 2013). Three of the latter used a one-group pretest/posttest design (Kazawa & 
Monyama, 2013; Lin et al., 2013; Walker et al., 2013) and one used a nonequivalent control 
group non-synchronized design (Choi & Lee, 2012). Two RCTs (Byrne et al., 2011; 
Williams et al., 2012) and one quasi-experimental study (Lin et al., 2013) were described as 
pilot or feasibility studies.
Sample/Setting—Subjects were recruited from out-patient nephrology or primary care 
clinics and hospitals. Studies were conducted in Australia (Williams et al., 2012), Canada 
(Flesher et al., 2011), Japan (Kazawa & Monyama, 2013), New Zealand (Walker et al., 
2013), South Korea (Choi & Lee, 2012), Taiwan (Lin et al., 2013), and the United Kingdom 
(Byrne et al., 2011). No studies were conducted in the U.S.
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The sample sizes ranged from 30 to 81 participants. Power calculations were used to 
determine sample sizes in three studies (Choi & Lee, 2012; Flesher et al., 2011; Williams et 
al., 2012); however, one study was unable to recruit the required number of participants 
(Flesher et al., 2011). Rates of subject accrual varied. Recruitment was hampered because 
potential participants did not meet inclusion criteria (Williams et al., 2012), lacked time and 
interest or were unaware they had problems with their kidneys (Byrne et al., 2011), were lost 
to follow-up after initial screening (Williams et al., 2012), or withdrew before intervention 
delivery (Williams et al., 2012). One investigator reported an inability to recruit (Flesher et 
al., 2011), but did not report problems encountered.
Mean age of the participants ranged from 57.5 (Walker et al., 2013) to 67 years (Kazawa & 
Monyama, 2013; Lin et al., 2013; Williams et al., 2012), and 52% to 69% were men (Byrne 
et al., 2011; Choi & Lee, 2012; Flesher et al., 2011; Lin et al., 2013; Williams et al., 2012). 
Smoking history was reported in two studies and 26% to 35% were current smokers (Walker 
et al., 2013; Williams et al., 2012).
Stage of CKD varied across the studies. Four (Choi & Lee, 2012; Flesher et al., 2011; 
Kazawa & Monyama, 2013; Williams et al., 2012) included participants in CKD Stages 3-4. 
Other investigations included participants with CKD stages 1-4 (Byrne et al., 2011), Stages 
1-3a (Lin et al., 2013) and Stage 2 (Walker et al., 2013).
Attrition rates varied in the studies reviewed. One (Lin et al., 2013) had a total attrition rate 
of 39%. Of the 44 subjects recruited, 37 completed the baseline measures and the 
intervention; of these, 27 completed all three posttests. The remaining 10 subjects dropped 
out due to unwillingness to complete follow-up or due to physical condition. In another 
study (Byrne et al., 2011), 37.5% of participants randomized to the intervention group did 
not attend the education session. Those who did attend were more likely to be older and 
have lower levels of self-efficacy. Attrition rates were 11% or less in the other studies 
(Flesher et al., 2011; Kazawa & Monyama, 2013; Williams et al., 2012), and reasons for the 
attrition included death, withdrawal, or refusal to take part in study protocol. One study 
reported no attrition (Choi & Lee, 2012) and another did not report attrition rates (Walker et 
al., 2013).
CKD Self-Management Interventions—The length of intervention sessions ranged 
from 30 to 180 minutes each (Byrne et al., 2011; Choi & Lee, 2012; Flesher et al., 2011; 
Kazawa & Monyama, 2013; Lin et al., 2013; Williams et al., 2012) with the number of 
contacts ranging from 1 to 36 (Byrne et al., 2011; Choi & Lee, 2012; Flesher et al., 2011; 
Kazawa & Monyama, 2013; Lin et al., 2013; Walker et al., 2013; Williams et al., 2012). In 
six studies, it was not clear whether participants attended all intervention sessions, if the 
group sessions lasted for the same lengths of time, or if participants stayed for the entire 
length of time. The length and content of telephone sessions (Williams et al., 2012) or the 
amount and content of e-mail messages (Kazawa & Monyama, 2013) were not described. 
The total duration of the contacts over time ranged from a single session (Byrne et al., 2011) 
to 6 months (Kazawa & Monyama, 2013). The mode for intervention duration was 12 weeks 
(Flesher et al., 2011; Walker et al., 2013; Williams et al., 2012). The dose of the control 
condition was not described in any reviewed study.
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The self-management intervention were provided on an individual level in three studies 
(Kazawa & Monyama, 2013; Walker et al., 2013; Williams et al., 2012) and on a group level 
in four others with group sizes ranging from 2-8 (Byrne et al., 2011; Choi & Lee, 2012; 
Flesher et al., 2011; Lin et al., 2013); one did not report group size (Flesher et al., 2011). All 
interventions were delivered face-to-face, although telephone (Kazawa & Monyama, 2013; 
Williams et al., 2012), e-mail (Kazawa & Monyama, 2013), videotapes (Lin et al., 2013), 
and a Digital Versatile Disc (DVD; Williams et al., 2012) were used. Motivational 
interviewing was used in one (Williams et al., 2012). Most were delivered at the institution 
(Byrne et al., 2011; Choi & Lee, 2012; Kazawa & Monyama, 2013; Walker et al., 2013), 
followed in frequency by home visits (Kazawa & Monyama, 2013; Walker et al., 2013; 
Williams et al., 2012), and at a gym (Flesher et al., 2011). Setting was not reported in one 
(Lin et al., 2013) and the location of a cooking class (Flesher et al., 2011) was not described.
In all studies, the interventionist was a nurse for at least one portion of the intervention. 
Other interventionists included a certified exercise physiologist (Flesher et al., 2011), cook 
educator (Flesher et al., 2011), and dietician (Choi & Lee, 2012; Flesher et al., 2011). In one 
study (Lin et al., 2013), the interventionist was identified only as a member of the research 
team. No peers, pharmacists, social workers, or health coaches were used as interventionists.
Use of a theory to guide study design or intervention development was reported in four 
studies. Two investigations (Byrne et al., 2011; Kazawa & Monyama, 2013) used social 
cognitive theory to examine the effect of self-management on CKD outcomes. In one (Lin et 
al., 2013), self-regulation theory was used to evaluate the effect of self-management on 
CKD progression. In the fourth study (Williams et al., 2012), the Health Belief Model was 
used to guide examination of the impact of an intervention to improve blood pressure 
control and adherence to medication. It was not clear, however, how central constructs of the 
theories were integrated into the intervention or study design. Moreover, intervention 
mechanisms were not tested in these studies. Use of a theory to guide the studies or 
intervention development was not reported in three studies (Choi & Lee, 2012; Flesher et al., 
2011; Walker et al., 2013).
Two investigators provided information about training providers. Skills were assessed in one 
study by observing a pilot session (Byrne et al., 2011), but no information was provided 
about how training occurred or how skills were maintained. In a second study (Kazawa & 
Monyama, 2013), the provider received lectures from CKD experts, participated in role 
playing the intervention, and team conferences ensured quality of the interventions over 
time.
Use of standardized instruction books was reported in three studies (Byrne et al., 2011; Choi 
& Lee, 2012; Kazawa & Monyama, 2013). One used a written script and checklist (Williams 
et al., 2012); content and results were not reported.
Receipt and enactment of the intervention by participants often went unreported. In one 
study (Kazawa & Monyama, 2013) self-monitoring data was reviewed to assess ability to 
perform skills, but other skills needed to initiate an action plan were not assessed. In another 
(Lin et al., 2013), it was not clear whether group discussions allowed comprehension of self-
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regulation strategies to be assessed, but participants self-evaluated actual performance of 
skills needed to meet short-term goals. Although a cooking and exercise class was 
implemented in another study (Flesher et al., 2011), no findings pertaining to receipt or 
enactment were reported.
Outcomes following intervention delivery
The effects of the self-management interventions were measured at different times, though 
all were at one year or less. The timelines included baseline to 8 weeks (Choi & Lee, 2012), 
baseline to 6 months (Kazawa & Monyama, 2013), and baseline to 12 months (Flesher et al., 
2011; Lin et al., 2013; Walker et al., 2013; Williams et al., 2012). In one study the 
measurement timeline was not stated (Byrne et al., 2011).
Annual decline in eGFR was the outcome measure in one study. In this study of 40 
participants (Flesher et al., 2011), eGFR declined by an average of 1.2% in the experimental 
group compared to an 11.2% decline in the control group at the 12-month follow-up; 
statistical significance and the method used to obtain the eGFR were not reported.
The eGFR was the targeted outcome in three other studies (Choi & Lee, 2012; Kazawa & 
Monyama, 2013; Williams et al., 2012) and a secondary outcome in another (Lin et al., 
2013). None of the studies had significant improvements in eGFR. In the three studies 
reporting nonsignificant findings for eGFR, one assessed physiological outcomes at 8 weeks 
(Choi & Lee, 2012), another at 3 and 6 months following the intervention (Kazawa & 
Monyama, 2013), and another at 3, 6, and 12 months following the intervention (Lin et al., 
2013).
Two studies (Choi & Lee, 2012; Lin et al., 2013) measured the estimated glomerular 
filtration rate (eGFR), derived from serum creatinine levels using the Modification of Diet in 
Renal Disease Equation (MDRD), two did not report method used (Flesher et al., 2011; 
Williams et al., 2012), and one used the formula by the Japanese Society of Nephrology 
(Kazawa & Monyama, 2013). It was not clear whether the metrics are similar in these 
different methods to allow comparisons.
Medication adherence was assessed in two studies (Kazawa & Monyama, 2013; Williams et 
al., 2012). Medication adherence significantly improved in a quasi-experimental study with 
30 participants (Kazawa & Monyama, 2013). In this study, medication adherence was 
measured by computing the self-reported days per month they took prescribed oral or 
injectable medications. In the second study, an RCT with 75 participants (Williams et al., 
2012), there was no significant difference in medication adherence when measured by either 
pill counts or self-report. The accuracy of using pill counts in this study was confounded by 
the fact that 30 of 75 participants had inaccurate or missing data.
Blood pressure was assessed in four studies with equivocal findings. In one RCT with 40 
participants (Flesher et al., 2011), the mean baseline blood pressure in the experimental 
group was 139/78 mm Hg reducing to 127/69 at 12 months compared to the control group 
which had a mean baseline blood pressure of 140/76 and 144/74 at 12 months; statistical 
significance was not reported. In two additional RCTs (Byrne et al., 2011; Williams et al., 
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2012) and one quasi-experimental study (Kazawa & Monyama, 2013), there were no 
significant improvements in blood pressure (see Table 2).
Hemoglobin A1C (HbA1C) was assessed by one investigative team and data were obtained 
from the medical record. In this quasi-experimental study of 30 participants, HbA1C 
significantly improved over time from baseline to 6-months, but was less than 7% at 
baseline using the Japan Diabetic Value (Kazawa & Monyama, 2013).
Dietary and exercise adherence were measured in one study and there was a significant 
increase in the frequency of exercise from 3- to 6-month follow-up, but no significant 
change in target dietary behaviors (Kazawa & Monyama, 2013). Adherence was assessed by 
computing the self-reported days per month engaged in dietary and exercise target 
behaviors.
Some investigators evaluated the effects of the interventions on disease-specific knowledge, 
self-management skills, and/or self-efficacy. The psychometric properties of the instruments 
were not fully described. Only one investigator evaluated change in knowledge using a 
dichotomous instrument. In this study, there were significant improvements in knowledge 
compared to controls (Choi & Lee, 2012).
Self-management was measured in four studies (Choi & Lee, 2012; Flesher et al., 2011; Lin 
et al., 2013; Walker et al., 2013) using four different self-report instruments. Only two of 
these investigators conceptually defined self-management (Flesher et al., 2011; Lin et al., 
2013) and it was difficult to determine if the conceptual definitions were consistent with 
operational definitions because instruments were not fully described. Self-management 
significantly improved in a quasi-experimental study with 61 patients 4 weeks following the 
intervention (Choi & Lee, 2012). In another pretest/posttest study of 52 participants, there 
was a significant increase in self-management at 3 months that was sustained at 12 months 
(Walker et al., 2013). Self-management did not significantly improve in another quasi-
experimental study of 27 patients (Lin et al., 2013) and was not statistically analyzed in an 
RCT of 40 patients although self-management was described qualitatively as improved 
(Flesher et al., 2011).
Self-efficacy was measured in three studies using three different instruments; significant 
improvements were reported in two. In one quasi-experimental study with 30 participants 
(Kazawa & Monyama, 2013), self-efficacy improved from baseline to 3 months and from 
baseline to 6 months when positive feedback was provided; additional improvement did not 
occur from 3 to 6 months. Self-efficacy also improved at 6- and 12-months in another quasi-
experimental study of 27 participants (Lin et al., 2013) when using modeling of self-
management behaviors and recognition of outcome performance as methods to enhance self-
efficacy. Self-efficacy results were not reported in a RCT with 81 participants (Byrne et al., 
2011).
As shown on Table 2, many other outcomes were assessed that included cardiovascular risk 
factors (Byrne et al., 2011); physiological indices, such as creatinine, hemoglobin, or blood 
urea nitrogen (Choi & Lee, 2012; Kazawa & Monyama, 2013; Lin et al, 2013; Williams et 
al., 2012), and quality of life (Kazawa & Monyama, 2013). Significant findings were 
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reported in only one. In this quasi-experimental study, there was a significant increase in 
serum sodium (Choi & Lee, 2012).
Discussion
The purpose of this paper was to review self-management interventions delivered to 
individuals with Stage 1-4 CKD to identify knowledge gaps and future directions for 
research. All seven of the reviewed studies were published between 2010 and 2013 and 
conducted outside of the U.S. The main findings were that (a) educational content was 
present in all, but was incomplete; (b) strategies to improve self-management varied and 
were limited in scope; (c) strategies to increase self-efficacy were largely undeveloped; (d) 
methodological limitations included flaws in design, sample size limitations, recruitment 
difficulties, attrition rates, and limited descriptions of the processes used in intervention 
delivery; and (e) outcomes varied across the studies and had equivocal findings. These 
findings are discussed below.
Interventions to improve acquisition of knowledge included some, but not all, of the key 
self-management behaviors associated with CKD. Content varied widely across studies and 
pharmacological content was included on a limited basis. Content on the avoidance of 
nonsteroidal anti-inflammatory drugs and tobacco avoidance was absent from all reports. 
Previous reports indicate patients with CKD want more information about their disease and 
how the underlying condition affects kidney function (Costantini et al., 2008; Mason, Stone, 
Khunti, Farooqi, & Carr, 2007), strategies to prolong function (Schatell, Ellstrom-Calder, 
Alt, & Garland, 2003), dietary modifications (Lewis, Stabler, & Welch, 2010; Mason et al., 
2007), medications that help or harm the kidney (Costantini et al., 2008; Lewis et al., 2010), 
and strategies for blood pressure control (Mason et al., 2007). Consistent and inclusive 
content is recommended in future work.
Interventions to enhance self-management behaviors were limited in scope. Self-
management interventions directed at lifestyle and exercise were included in some 
interventions (Flesher et al., 2011; Kazawa & Monyama, 2013; Walker et al., 2013); content 
on smoking cessation was absent. These are important areas to emphasize so patients have 
the prerequisite knowledge to make important decisions for kidney health and engage in 
effective self-management behaviors. In a secondary analysis of data from 2,615 CKD 
patients (Tuot et al., 2013), 89% avoided tobacco and 24% engaged in frequent physical 
activity.
People with CKD have described self-management as active engagement in treatment 
requiring daily self-management decisions. These individuals reported lack of guidance on 
skill building as a major barrier to self-management (Costantini et al., 2008), suggesting 
self-management skills are important and needed by people with CKD. In our review, the 
self-management skills of action planning, problem-solving, and enhancing patient-provider 
partnerships were evident in some CKD self-management interventions; decision making, 
resource utilization, and self-tailoring were not evident. Moreover, the interventions focused 
on the self-management tasks associated with medical management, but tasks associated 
with role and emotional management were absent. Self-management interventions that 
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include skill development in these areas have improved patient outcomes in other patient 
populations (Bissonnette, Woodend, Davies, Stacey, & Knoll, 2013; Nuno, Coleman, 
Bengoa, & Sauto, 2012; Shively et al., 2013). Possible strategies to consider for inclusion in 
future CKD self-management interventions are (a) use of action planning tools or eHealth 
self-management applications (U.S. Department of Defense, 2012); (b) inclusion of methods 
to help patients remember what they need to ask their provider at routine visits, how to best 
report their problems or concerns and what they have done to alleviate the problem, and/or 
how to have serious discussions with their provider about health decisions; (c) providing a 
list of Web sites that include accurate and appropriate content and, as appropriate, teaching 
patients how to use and navigate through the sites; (d) providing resources where patients 
can find information, such as who to contact for help to learn to read food labels or quit 
smoking; and (e) providing a list of helpful smartphone apps, such as My MedSchedule, 
MyMeds, and RxmindMe (Dayer, Heldenbrand, Anderson, Gubbins, & Martin, 2013).
Prior research suggests patients with CKD want more information about decision making 
(Schatell et al., 2003). People with CKD must make daily decisions when taking care of 
themselves at home and must have accurate and complete information when responding to 
changing conditions (Lorig & Holman, 2003). The creation of important messages to 
support decision making is fundamental to self-management education (Lorig & Holman, 
2003). Refinement of CKD self-management interventions should involve messages 
surrounding the following questions: (1) If I can no longer take NSAIDS, what options do I 
have when I experience minor aches and pains due to a headache, muscular aches, menstrual 
cramps, a backache, or arthritis? (2) What do I do if potassium or phosphorus content is not 
listed on a food label? (3) When should I contact my doctor for blood pressure or blood 
glucose readings that are higher or lower than normal? (4) What should I do if I become ill 
and am unable to take my ACE-I or ARB? (5) Should I continue taking my ACE-I or ARB 
even when my blood pressure is low? (6) What short-term strategies can I consider to begin 
a regular exercise regimen? (7) How do I know whether a new symptom is serious? Creation 
and use of decision aids (U.S. Department of Defense, 2012) may facilitate development of 
decision-making skills.
Strategies for increasing self-efficacy were largely underdeveloped or not described. Further 
development is needed, as supported by findings from a descriptive study of 174 CKD 
patients in which higher self-efficacy was associated with better self-care (Curtin et al., 
2008). Because CKD often coexists with other chronic diseases, such as diabetes, heart 
failure, and hypertension (U.S. Renal Data System, 2013), an integration of interventions for 
all chronic conditions is suggested to help improve self-efficacy and self-management 
(Dickson, Buck, & Riegel, 2013).
There were numerous methodological limitations in the reviewed studies. Half of the studies 
were quasi-experimental and three of these used a pretest/posttest design. Although it was 
not clear why less rigorous designs were chosen, they may have been selected because many 
were pilot or feasibility studies. No further development of these trials, however, has been 
reported to date.
Welch et al. Page 10
West J Nurs Res. Author manuscript; available in PMC 2016 May 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Recruitment was a major difficulty. Although lack of CKD awareness was cited as a reason 
for recruitment difficulties in only one study (Byrne et al., 2011), it may have been a factor 
affecting recruitment in other studies as well. In two large trials including a total of over 
4,400 patient, 84-94% were unaware they had CKD (Tuot et al., 2013). Although prior 
research indicates that as CKD advances, CKD awareness and treatment improves (Sarafidis 
et al., 2008), slowing disease progression early is imperative. One promising strategy to 
improve awareness uses a one-page educational worksheet that physicians review with 
patients. Patients exposed to the worksheet were more likely to know they had CKD, their 
kidney function, and their stage of CKD (Nunes et al., 2013). A recent meta-analysis with 
older adults clearly showed that one-page succinct worksheets were effective for improving 
medication adherence (Conn et al., 2009).
Studies lasted for one year or less and were based on a single or short-term intervention 
designed to improve self-management in a slowly progressive disease. A recent report 
indicates that self-management behaviors do not develop in a uniform pattern (Audulv, 
2013) suggesting that booster interventions may be needed throughout the course of a 
chronic illness.
Sample sizes were small and often had insufficient power. The racial composition of 
participants was seldom reported. Future researchers may want to consider enrolling 
adequate numbers of diverse participants to permit meaningful comparisons of intervention 
effects by race or ethnicity. Similarly, health literacy was not reported, although 
understanding health literacy in CKD patients would allow us to consider this factor during 
intervention refinement and testing.
Attrition was a problem in some studies which was particularly troublesome given the small 
sample sizes. It may be helpful in future studies to describe the activities to increase study 
participation. The use of incentives might be a beneficial way to thank participants for their 
time and effort given the significant time required for intervention delivery.
The self-management interventions in the studies reviewed were delivered on an individual 
or group level, and family members were not evident. No investigator examined whether 
one delivery mechanism was superior to another. Although interventionists were primarily 
and appropriately nurses, several other disciplines involved in nephrology care were 
omitted, such as pharmacists and social workers, who may need to be included in the future 
for their specialized knowledge and expertise. Consideration should be given to the 
inclusion of health coaches or use of peer mentors because they have been efficacious in 
previous chronic disease self-management investigations (Castro, Pruitt, Buman, & King, 
2011; Long, Jahnle, Richardson, Loewenstein, & Volpp, 2012; Thom et al., 2013). Training 
of the interventionists was seldom described. Although presumably the interventionists had 
the technical and interpersonal skills to carry out intervention delivery, planned delivery of 
the intervention relies on the interveners' understanding of the essential features of the 
intervention and any variability may affect outcome achievement (Melnyk & Morrison-
Beedy, 2012). Although the length of the intervention was often provided, no information 
was provided about actual attendance or whether participants received the entire intervention 
as planned. Future investigations may want to consider proactive development of strategies 
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to assess delivery, receipt, and enactment of the intervention because these data were often 
omitted from reports.
One of the principles for implementing self-management support is the use of diverse 
formats (Battersby et al., 2010). None of the interventions used information technology (IT). 
A recent report indicates that 76% of U.S. households have a computer and 72% have access 
to the Internet (File, 2013), suggesting that IT would be a viable option for delivery of 
chronic disease self-management interventions. Creative marketing approaches to make 
CKD self-management interventions available in rural areas, primary care, or family 
practice settings may be invaluable in slowing disease progression. Although one CKD self-
management program has been designed using IT (Ong, Jassal, Porter, Logan, & Miller, 
2013), its efficacy has not been tested.
Use of a health behavior theory guided study design or intervention development in four 
studies (Byrne et al., 2011; Kazawa & Monyama, 2013; Lin et al., 2013; Williams et al., 
2012). Future work might want to consider use of the Self and Family Management 
Framework (Grey et al., 2006) or the Individual and Family Self-Management Theory (Ryan 
& Sawin, 2009). In addition, level of patient activation was not included in any 
investigation. Future researchers may want to consider tailoring or targeting interventions to 
activation level because changes in activation are often accompanied by changes in self-
management behaviors (Hibbard, Mahoney, Stock, & Tusler, 2007; Shively et al., 2013; 
Solomon, Wagner, & Goes, 2012). Targeting interventions to activation level creates a level 
of self-management support that meets the needs of individuals at specific points in time, 
leading to more adherence to their healthcare providers' recommendations (Hibbard & 
Mahoney, 2010) and better health outcomes (Hibbard & Greene, 2013).
Outcomes varied and had equivocal findings across the reviewed studies. The primary 
outcome assessed in the studies was eGFR. Future investigations may want to consider the 
best time to measure this important outcome and conduct the study over a long enough 
period of time to assess the efficacy of the intervention. This will be an important 
consideration to help investigators decide if or when booster interventions are needed to 
assist participants as they live with and manage their CKD over time.
Strong evidence supports use of ACE-I and ARB therapy to slow progression to kidney 
failure (Fink et al., 2012). Medication adherence was included as an outcomes in only two 
studies (Kazawa & Monyama, 2013; Williams et al., 2012) and should be considered an 
important outcome associated with CKD self-management. Patients are often overwhelmed 
by the number of medications they must take, and the perceived barriers to medication 
taking often outweigh the benefits (Williams & Manias, 2014) as evidenced by 50% 
nonadherence to ACE-I or ARB therapy (Chang et al., 2012). Numerous approaches are 
available to measure medication adherence (Bosworth, 2006) and electronic monitoring is 
widely considered the best measure (Demonceau et al., 2013). Since medication taking is a 
dynamic behavior, electronic monitoring provides long-term information on the date and 
time medications are accessed for presumed medication administration (Dunbar-Jacob, 
Sereika, Foley, Bass, & Ness, 2004). Providing feedback on medication taking using printed 
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reports from electronic monitors shows great promise as an intervention for improving 
medication adherence (Demonceau et al., 2013).
Future investigators may want to examine the effects of the intervention on mechanism of 
action to validly interpret outcomes (Melnyk & Morrison-Beedy, 2012). The psychometric 
properties of the instruments used to measure knowledge, self-management, and self-
efficacy were not completed reported and instruments may need additional psychometric 
testing.
In summary, the knowledge gaps identified following this review were as follows: (a) the 
focus of the papers reviewed were on medical self-management tasks and no attention was 
given to the role or emotional tasks that people may face when diagnosed with Stages 1-4 
CKD, (b) there was lack of family involvement during intervention delivery, and (c) 
although there is considerable evidence that disease management interventions are effective 
and efficient (Hisashige, 2013); the ability to form conclusions about the efficacy of 
interventions designed for people with Stages 1-4 CKD was hampered because 
methodological rigor was insufficient. Despite the difficulties in drawing conclusions, 
recommendations for future work can be proposed. Further development and refinement of 
interventions are needed that consider acquisition of knowledge, development of self-
management skills, enhancement of confidence, and the role patient activation has for 
adherence. All core self-management skills should be addressed in future studies. Use of a 
theory to guide the studies or intervention development is recommended. Careful attention 
should be given to training of interventionists, length of interventions, and delivery, receipt, 
and enactment of the interventions. Future work should use rigorous methodologies such as 
use of randomized controlled trials, increased sample sizes with sufficient power to detect 
group mean differences, a sampling plan that allows recruitment of a large enough sample 
size, and use of strategies to minimize attrition. It would be helpful to determine if there are 
changes in intervention mechanisms following intervention delivery to allow a better 
evaluation of outcomes. Future work should pay particular attention to important clinical 
outcomes, such as eGFR, medication adherence, blood pressure, HbA1C, diet and exercise 
adherence, and health-related quality of life.
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Table 2
Methods and Outcomes of Self-Management Interventions Tested with People who have 
Stage 1-4 Chronic Kidney Disease (CKD)
First author Design and sample Characteristics of intervention Outcomes
Byrne Design: RCT; feasibility 
study (2 groups: 
intervention, control)
Sample: N = 81
CKD Stage: 1-4
Dose of intervention
Length of contact session: 2 ½ hour
Number of contacts: 1
Groups of 2-6 participants
Dose in comparison condition
NR
Setting
Educational area within hospital
Interventionist
Study nurse
Theoretical model
Social cognitive theory
Significant difference:
None
No statistical difference:
B/P (data not provided)
Cardiovascular risk factors 
(data not provided)
Not reported:
Self-efficacy
Choi Design: Quasi-
experimental; 
nonequivalent control 
group non-synchronized 
design. (2 groups: 
intervention, control)
Sample: N = 61
CKD Stage: 3-4
Dose of intervention
Education sessions
Length of contact session: 90 minutes
Number of contacts: 3 sessions
Groups of 3-5 people
Individualized consultation
Length of contact session: 20 minutes
Number of contacts: 1
Reinforcement of education following education and 
consultation 1 week later: length NR.
Dose of comparison condition
NR
Setting: Seminar room in hospital
Interventionist: CKD expert panel including 5 physicians, 3 
nutritionists, and 5 nurses
Theoretical model: NR
Significant difference:
CKD knowledge (p < .001)
Self-care (p = .001)
Serum sodium
No statistical difference:
Blood urea nitrogen
Creatinine
Serum sodium
Serum potassium
Serum calcium
Serum phosphorus
Hemoglobin
GFR (using MDRD)
Flesher Design: RCT (2 groups: 
intervention, control)
Sample: N = 40
CKD Stage: 3-4
Dose of intervention
Individualized nutrition counseling in both groups: length, 
number of contacts, and duration of contact NR
Cooking class:
Length of contact sessions: 2 hours
Number of contacts: 4
Duration of contact over time: 4 weeks
Group cooking class included a shopping tour led by dietitian
Exercise class
Length of contact session: 1 hour
Number of contacts: 36
Duration of contact over time: 12 weeks
Counseling:
Length, number, and duration of contacts NR
Dose of comparison condition
Dose of standard nutritional care NR although a detailed 
description of standard nutritional care was provided.
Setting: unknown for nutrition class; exercise class took place 
in a gym
Interventionist: dietitian, cook educator, certified exercise 
physiologist, nurse.
Theoretical model: NR
Significant difference
14 of 23 people in 
experimental group and 2 of 17 
people in control group had 
improvement in 4 of 5 
endpoints (B/P, GFR, total 
cholesterol, urinary protein, 
urinary sodium); (p = .03)
Self-management (qualitative):
Experimental group indicated 
improvement in exercise 
frequency, concern over heath 
condition, frequency of visits 
to health care provider, and 
hospitalizations.
Control group indicated 
improvement in 
communication with health 
providers.
No statistical difference:
None
Kazawa Design: Quasi-
experimental; one-group 
pretest/posttest
Sample: N = 30
CKD Stage: 3-4
Dose of intervention:
Session 1-4 face-to-face meetings
Length of contact session: 1 hour
Number of contacts: 4
Duration of contact over time: 8 weeks
Session 5-6 by telephone or e-mail
Length of contact session: 30 minutes
Number of contacts: 2
Duration of contact over time: 2 months
Monthly telephone follow-up and length and number of 
contacts NR
Duration: 6 months
Consultation with a dietician provided when requested; length 
of contact, number of contacts, and number requesting NR
Dose of comparison condition
Significant difference
Self-efficacy (p < .01).
Exercise target behaviors (p <.
05).
Frequency of self-monitoring 
(p < .001).
Frequency of drug intake and 
injection (p < .01).
HbA1C (p < .05)
No statistical difference:
Albumin
B/P
BUN
Body mass index
Dietary behaviors
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First author Design and sample Characteristics of intervention Outcomes
No control group
Setting
Individualized face-to face meetings occurred at participants' 
homes or the out-patient clinic.
Interventionist
Five nurses
Theoretical model
Social cognitive theory
Hemoglobin
Lipid profile,
Phosphorus
Potassium
Quality of life
Serum creatinine
Total protein
Lin Design: Quasi-
experimental; single-
group pretest/posttest; 
pilot study
Sample: N = 37
CKD Stage: 1-3a
Dose of intervention
Length of contact session: 90 minutes
Number of contacts: 5
Duration of contact over time: 5 weeks
Groups of 6-8 participants each week
Dose of comparison condition
No control group
Setting: NR
Interventionist
Lead investigator (a nurse)
Theoretical model
Self-regulation theory
Significant difference
Self-efficacy (p < .05)
No statistical difference:
eGFR using MDRD
Self-management
Serum creatinine
Walker Design: Quasi-
experimental; pre- and 
post-test design; pilot 
study
Sample: N = 52
CKD Stage: 2
Dose of intervention
Length of contact session: NR
Number of contacts: 6
Duration of contact over time: 12 weeks
Dose of comparison condition
No control group
Setting: primarily in clinic or in participants' homes if 
preferred
Interventionist
Nurse practitioner working with primary practice nurses and 
general practitioners.
Theoretical model
NR
Significant difference
Self-management (p < .001)
No statistical difference:
None
Not reported:
Secondary data analysis; main 
findings reported in another 
paper under review.
Williams Design: RCT; feasibility 
study (2 groups; 
intervention, control)
Sample: N = 75
CKD Stage: 3-4
Dose of intervention
Intervention home visit included a 20-minute DVD that used 
interactive and psychosocial approach for motivating people to 
take medications appealing to knowledge, thoughts, and 
feelings based on Health Belief Model.
Length of contact session: mean 89 minutes
Number of contacts: 1
Motivational interviewing via telephone sessions
Length of contact mean 11.8 minutes
Number of contacts: 6
Duration of contact over time: 12 weeks
Dose of comparison condition
NR
Setting: Home of participant.
Interventionist: One doctorally prepared nephrology nurse who 
had training in motivational interviewing.
Theoretical model
Health Belief Model
Significant difference
87% adherence to taking B/P 
daily at 3 months in 
experimental group.
No statistical difference:
B/P
Medication adherence
Not reported:
Improvement in eGFR and 
serum creatinine reported, but 
not statistically analyzed for 
group mean differences.
B/P = blood pressure; BUN = blood urea nitrogen; eGFR – estimated glomerular filtration rate; MDRD = Modification of Diet in Renal Disease 
Equation; NR = not reported; RCT = randomized controlled trial
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